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Abstract
Purpose: The development of control systems to
sustain the level of healthcare-associated infections
(HAIs) is an emerging issue for healthcare manage-
ment. This is partly due to the perception that HAI
became a serious negative impact factor on the
performance of healthcare organizations and on
related public health dimensions. Throughout the
decade of 1990 a significant number of international
programmes were developed to understand and to
promote effective HAIs prevention and control
systems: Patient Safety and the quality improvement
of healthcare organizations became common con-
cepts in healthcare management. However, regard-
less of advances in infection control systems, the
rates of incidence of HAIs remained relatively
unchanged in the last decades. The purpose of this
study is to point out barriers that recent inter-
national literature has identified as factors hindering
the successful development of control systems to
prevent HAIs. The international debate on possible
alternatives to strengthen this common healthcare
management issue, benefits form one such update.
Methods: A literature review was conducted in a
3-month period by two investigators. The BioMed
Central, Pubmed, Emerald, and B-on databases
were searched for articles published between
January 2006 and September 2011. A standard
form was created for data extraction.
Findings: A total of 49 articles met inclusion criteria.
Within the analysed articles, 26 were developed in
Europe, 15 were developed in North America; 6
were developed in Asia, and 2 in Australia. Thirty
(30) different barriers to effective HAIs control
systems were identified. The barriers were clustered
by dimensions and sub-dimensions. The largest
number of barriers clustered, are associated with
structures and processes and also barriers associated
with healthcare management processes.
Keywords: Healthcare-associated infections, Control
systems, Healthcaremanagement, International review
Background
Concerns on healthcare-associated infections (HAI)
are not a recent healthcare management issue. The
work of Florence Nightingale already indicated
that, in the nineteenth century, there was awareness
of the need to control infections in military hospi-
tals.1 And of the fact that infections were a leading
cause of death in hospitals lacking control and due
to, among other factors, a lack of knowledge on
the mechanisms of transmission which began to be
identified at the end of the nineteenth century.2,3 A
structured approach to this problem promoted the
adoption of methods of basic hygiene, along with
the use of antiseptics during surgery, thus, originat-
ing the first hospital infection control systems. This
problem, however, has become more distinct in its
true dimension at the end of the twentieth century,
and is now one of the major healthcare management
challenges worldwide. A number of factors deter-
mined the increasing relevance of the issue in the
past three decades: more patients are more suscep-
tible to infections, increase of invasive procedures
and related higher risks of infection, mixed popu-
lations of patients within the hospital environment
promoting the risk of crossing transmission, increase
of microbial resistance, inadequate methods of
cleaning and hygiene, lack in healthcare manage-
ment leadership to implement control systems, and
reduced commitment of top management to tackle
the problem of hospital infections.4,5
We can argue that the year 2000 is a keymoment in
the recent history of health systems as the problem of
HAIs acquired the status of being an emerging
issue for healthcare management due to negative
impact on performance of healthcare organizations,
specifically in three dimensions of the performance
assessment tool for quality improvement in hospitals
(PATH): clinical effectiveness, safety, and patient-
centeredness.6,7 The dimension of ‘patient safety’
became a prominent issue in a report published in
2000 by the Institute of Medicine (IOM), entitled
‘To err is human: building a safer health system’, in
which the international health management
community became aware of shocking numbers of
harm associated with medical errors and adverse
events from related practice in healthcare organis-
ations. It was also verified that the error rate in
healthcare was higher than the error rate observed
in others risk sectors (e.g. aviation) but the risk
management systems were much more primitive
than others developed for others risk sectors.6–8
In 2001, the Agency for Healthcare Research and
Quality (AHRQ) initiated a large study on Healthcare
practice and patient safety. Through a comprehensive
analysis of literature and ‘experts’ opinion 79 types of
practicewere not only identifiedmostly related to inpa-
tient setting but also including outpatient setting.
Among various risk factors identified, the report high-
lighted some main problems related to incidents
reporting, organizational issues on quality/safety (i.e.
legislation, accreditation, market regulation require-
ments, professional regulation, and healthcare pro-
fessionals’ compliance levels), infection control
systems and policies (i.e. surveillance systems at all
levels and healthcare practice) and healthcaremanage-
ment systems (i.e. leadership, top management com-
mitment, and team management) amongst the main
areas identified.9,10 Subsequently to this large study,
new recommendations for hospital infection control
systems were developed, especially aimed at health-
care professionals behaviour-related factors, as well
as related to management of hospital structures (i.e.
environmental and resources usage) and also aimed
at reviewing clinical and healthcare management
processes.10–23
In essence, as we presented in previous research,
there have been a significant number of international
programmes developed to understand and to
promote the HAIs prevention and control systems
and, consequently, improve patient safety and
quality improvement of healthcare organizations.24
In line with advances in implementing infection
control systems, we assume that it is relevant to
identify and discuss the constraints for the success
of HAIs prevention and control systems. To contrib-
ute to this focussed debate, we developed a literature
review aimed at producing an international update
on barriers identified in recent published research.
Methods
Search strategy
The BioMed Central, Pubmed, Emerald, and B-on
databases were searched for articles published
from 2006 to September 2011 within a set of
inclusion and exclusion criteria (Table 1).
A number of titles and abstracts were retrieved for
each term and evaluated for relevance. From the rel-
evant abstracts another set of free-text keywords
were retrieved to focus the analysis. After selecting
the relevant terms (7) and free-text keywords (12)
it was then performed a universal search in the data-
bases followed by retrieval of relevant articles,
based on the title and abstract (Table 2).
Using a combination of at least one of these head-
ings/terms and one of the free-text keywords as
Table 1: Inclusion and exclusion criteria
Inclusion criteria
(a) Contain abstract;
(b) Be published and available in a journal in public
domain;
(c) Address an issue related to HAIs Prevention and
Control Systems in hospitals;
(d) Contain a description about HAIs issue study;
(e) Contain a description of the barriers or
constraints to prevention and control of HAIs;
(f ) Discuss HAI’s control systems relevant results
about structures (resources, environmental
conditions, organizational culture/values),
process (clinical processes – best practices,
therapy process, and management processes)
and results (data, data quality, report);
(g) Contain quantitative data about at least one
dimension of Healthcare-associated infection:
Patient safety, infection type, hospital
characterization (including dimension, structure,
resource utilization, planning issues),
management issues (programs/methodologies
to control infection), communication issues (tools
channels, processes, data available) and others;
(h) Have been published between January 2006 and
September 2011
Exclusion criteria
(a) Articles not related with healthcare issues
(b) Articles analysing care processes
(c) Non Developed or Developing Countries
(d) Projects with main purpose of financial
improvement
(e) Articles analysing change in software and/or
hardware and Information Technology;
(f ) Articles with description of methods, models and
theories without empirical data.
well as the inclusion criteria ‘publication period’, we
identified 878 articles from Pubmed, 307 from
BioMed Central, 281 from B-on, and 108 from
Emerald. After this initial selection all the other
inclusion/exclusion criteria were applied and the
number of articles to be analysed was reduced to
74 articles from Pubmed, 46 from BioMed Central,
74 from B-on, and 14 from Emerald. Two reviewers
independently scanned and evaluated all articles for
consideration, and together decided whether or not
to obtain the full text article. After this analysis a
selection of 49 articles met all the inclusion criteria
(see Fig. 1). Full publications of all selected abstracts
or articles were obtained (electronic/printed form).
All the articles were in English language.
Data collection and content analysis
A standard form was created for data extraction in
Excel with the following labels:
• country or region;
• publication year;
• method
• study setting (hospitals, teaching hospitals,
military hospitals, wards hospitals, and inten-






Table 3 summarizes data extraction results. A total of
38 articleswere research studies and 11were reviews.
Of the articles identified, 25 were developed in
Europe, 16 in North America; 6 in Asia, and 2 in
Australia. One of the studies analysed more than
one country (Switzerland and Germany). More
than one study reported more than one country
information. More than one article identified more
than one barrier to HAIs control systems.
Results
From the literature review performed, we were able
to identify a set of barriers to the success of HAIs’
prevention and control programmes (see Table 4).
These barriers were clustered in the three dimen-
sions (structure, processes, and results), based in
the Donabedian Triology developed to evaluate
quality of care.25,26 We assume that a healthcare
organization is framed in an external context,
divided into macro context (indirectly related with
the organization, such as legislation/regulation,
society, and others) and a micro-context (directly
related with the organization, including suppliers,
patients, patients’ families, and others). Any analy-
sis of an healthcare organization can be divided in
answering to concrete questions such as ‘Who we
are…’, and this includes ‘structures’ and its four
sub-dimensions (infrastructures, resources, environ-
mental conditions, and cultures/values), ‘How we
do…’ being the ‘processes’ and its two dimensions
(clinical processes and management processes),
and ‘What we get…’ as results, divided in two
sub-dimensions (data and reporting/communi-
cation) (Fig. 2). In this study we only analyse organ-
izational barriers in relation to HAIs.
On the basis of this modelled approach we
identified a number of barriers from the literature
review undertaken. Below, the dimension and






















Figure 1: Search strategy.
sub-dimension identified are presented with
additional information concerning the published
articles in which each set of barriers were identified
(Table 4).
Discussion
A total of 49 articles met the inclusion criteria
defined for the literature review performed. From
these articles it was possible to identify 30 barriers,
clustered by dimension/sub-dimension. A detailed
analysis of the table shows barriers associated with
structures and processes represent the bulk of bar-
riers to implementing control systems to prevent
HAIs followed by barriers associated with
processes.
On the ‘structures’ there are the barriers related to
infrastructures (hospital size and hospital level) and
to resources, mainly associated with lack of health
professionals – especially nurses – dedicated on
a full-time basis to HAIs prevention and control
programmes, as recommended internationally.16,27
The barrier most identified in the largest number
of articles pertains to ‘environmental contami-
nations’. It was given the relevance of this barrier
in the HAIs prevention and control, that CDC and
Healthcare Infection Control Practices Advisory
Committee (HICPAC) launched in 2003 and in
2008, respectively, a set of recommendations for
Environmental Infection Control, Disinfection and
Sterilization of Healthcare Facilities. Among the
related recommendations it stands out, among
other factors, the importance of the involvement of
health professionals associated with the infection
control programme at all stages of development of
infrastructure/environment, as well as identifi-
cation/risk assessment and related construction
barriers. These organizations suggest the creation
of multidisciplinary teams constituted by both
those responsible for infrastructure and health pro-
fessionals to maximize the effectiveness of infection
control programmes.13,28 Interestingly, the work
carried out by Liyanage and Edgu2 went further
arguing for integrated management of infrastructure
at the level of environmental contamination and clini-
cal practice in order to better integrate processes and
practices undertaken by both clinical and nonclinical
activities in interventions for HAIs prevention and
control. Also related to the ‘structure’ dimension a
study commissioned in 2001 by the AHRQ on safe
practice presents ‘organizational culture’ as key to
improving patient safety. Other authors also argue
that medical practice must also take into account
the issues related to structures – culture and values
to improve the overall quality of healthcare.29,30
The review performed allows us to state organiz-
ational processes are the source of the largest diver-
sity of barriers to successfully implement effective
HAIs prevention and control programmes. On the
‘clinical processes’ sub-dimension, the barrier
‘poor infection control practices’ is a key point.
This barrier encompasses a range of factors high-
lighted in the literature reviewed as being primarily
responsible for the difficulty of the HAIs control
Table 3: Data extraction results.
Country/region Method
Australia 2 Research article (38)
Canada 1 Prospective study 23
Finland 1 Retrospective study 5
France 2 Modelling study 8
Germany 2 General research 2
Hong Kong 1 Review article (11)
Italy 4 General review 7
Japan 4 Systematic literature review 4
The Netherlands 1
Portugal 1 Barriers per dimension/sub-dimension
South Korea 1 Structure (13)
Switzerland 2 Infrastructures 3
Spain 2 Resources 7
UK 11 Environmental conditions 2
USA 15 Culture and values 1
Process (14)
Settings (Hospitals) Clinical processes 7
Community hospitals 47 Management processes 7
Teaching hospitals 1 Results (3)
Military hospitals 1 Data 2
Reporting/communication 1
Table 4: Barriers identified in the studies.
Dimension Sub-dimension Barrier identified Study*
Structures
‘Who we are’
Infrastructures Hospital level (type of ward, size, and type
of services)
(2), (5), (22), (45)
Structure limitations for isolation
precautions
(30)
Overcrowding wards (8), (17)
Resources Under-resourced infection prevention
programmes (budget, staff, etc.)
(3), (4), (38)




Temporary nursing staff and reduced
number of FTE (fulltime equivalent)
associated to infection control (less than
the recommended standard)
(17), (19), (20), (35), (41)
Time consumed by the surveillance
programmes
(25)
Home laundering instead of industrial
laundering
(48)




surfaces, floor, bed linen, and others)
(1), (6), (7), (8), (12), (17),
(23), (30), (32)
Clothes contamination (e.g. white coats) (46), (48)
Culture and
values
No compliance with infection control
culture, policies, and social norms (e.g.
wearing uniforms in public spaces,
resistance to apply rules/standards in
practice – more doctors than nurses)
(4), (14), (18), (22), (48)
Processes
‘How we do’
Clinical processes Poor infection control practices (guidelines
inconsistently implemented, disinfection
not appropriately performed on clinical
practice, hand hygiene no compliance,
insufficient use of protective equipment,
lack in understanding the exact
mechanism of pathogen transmission)
(1), (7), (8), (9), (11), (12),
(13), (14), (17), (20),
(22), (23), (31), (32),
(36), (39)
Biological factors, intubation process,
blood transfusion, invasive procedures,
and treatment duration (long stay in
hospital)
(17), (21), (27), (29), (34),
(43), (44)
Risk factors identification (26)
Therapy (use of antibiotics, antimicrobial
resistance)
(16), (26), (27), (31), (35)
Reactive practice instead proactive practice (30)
HAIs definition (definitions, ICD codes
limitations for HAIs classification)
(3), (41)





Awareness, perceived risk, individual
attitude, individual behaviour
(healthcare professionals)
(5), (13), (22), (36), (39)
Knowledge, education, and training (5), (12), (13), (17) (36),
(39), (41)
Lack of information/quality of information
(colonized patients in real time,
persistence of pathogen agents on
inanimate surfaces, swabs, or clinical




systems, with emphasis on the noncomplicance of
health professionals to hand-hygiene procedures.
This behavioural factor has been identified as a
key element for HAIs prevention and control and,
although it is considered a simple action, the lack
of compliance among healthcare providers is still
problematic worldwide. The cause of this phenom-
enon is often associated with structural factors (i.e.
workload, type of wards, and accessibility to hand-
hygiene resources) and process factors (i.e. knowl-
edge, training, perceived risk, and individual atti-
tude). Aware of this problem, the CDC and the
World Health Organization (WHO) developed a
range of strategies for hand-hygiene promotion and
improvement. For this purpose the WHO proposed
the First Global Patient Safety Challenge, ‘Clean
Care is Safer Care’, focusing part of its attention on
improving hand-hygiene standards and practices in
healthcare along with implementing successful
interventions.11,31,32 Another important related
phenomenon pertains to the poor quality of infection
control programmes mirroring the fact that these are
designed with no support from scientific evidence
and inconsistently implemented including the
lack of organisational epidemiologic surveillance
programmes. For this reason the WHO developed,
in 2009, guidelines on the core components of
Infection Prevention and Control Programmes.16
Further to this, two other key factors are identified
systematically in the international literature
reviewed: clinical procedures (such as invasive pro-
cedures) and therapy. Related to the former we
identified several articles dedicated to the subject.
It stands out the analysis made by the AHRQ on
patient safety practices. In this work, the interven-
tions undertaken to minimize the effects of invasive
procedures in patient safety are analysed in detail.9
Given the importance of invasive procedures
(surgery, invasive devices) in HAIs prevention and
control the CDC developed in 2002 (updated in
2011) some guidelines for the prevention of intravas-
cular catheter-associated infections12,28 and guide-
lines for disinfection and sterilization in healthcare
facilities.28 The WHO, in 2009, also launched the
Second Global Patient Safety Challenge – Safe
Surgery Saves Lives.33,34 On what concerns
therapy, it has been argued that this is one of the
major concerns worldwide and a large number of
articles demonstrate that inadequate therapy,
besides being one of the main responsible for
HAIs, is also one of the main responsible for antimi-
crobial resistance, such as MRSA.4,35–37 To combat
the specific problem of therapy control, the CDC,Figure 2: Healthcare organization model.
Table 4: Continued
Dimension Sub-dimension Barrier identified Study*
Support operations (ward, bed occupancy,
patient turnover, teams management
and relationship, workload, domestic
services, use of resources, and
responsibilities definitions)
(1), (5), (8), (18), (19), (24),
(28), (30), (35)
Lack in the assessment/evaluation
methods (ethical limitations, business
case, cleaning spaces, hand hygiene, and
cost-effectiveness analysis)
(3), (11), (12), (18), (22),
(43)
Lack in leadership (19), (22), (26), (33)
Lack in the surveillance methods (no
standardized methodologies)
(15), (25), (35), (37), (38)
Results ‘What
we get’
Data Lack of data (no data, susceptible to error,
underestimated infections rates)
(8), (9), (10), (25), (37),
(40)
Data treatment/analysis limitations (41), (49)
Reporting/
communication
Lack in the reporting systems (including
feedback, report errors)
(2), (10), (26), (35), (41),
(42)
*The numbers pointed refer to the articles reviewed (see references in the Appendix).
the WHO, and the European Union have been
developing since 2001 a set of recommendations
and programmes to assist healthcare organizations
in the HAIs prevention and control.24,38
Related to ‘processes’ the literature reviewed
allows to add further relevant barriers: ‘support
operations’, ‘awareness’, ‘knowledge’, ‘surveillance
methodologies’, ‘leadership’, ‘assessment/evalu-
ation methods’, and ‘surveillance programmes’.
Factors considered to be the causes of failures in
these healthcare management activities, include dif-
ficulties associated with ward management, health-
care team management, hospital and cleaning
services management, role definition, and
inadequate use of resources. Some authors also
identified poor knowledge management as an
important factor hindering organizations’ capacity
to better integrate processes and practices developed
clinical and nonclinical activities, better team man-
agement and definition of roles for HAIs prevention
and control programmes.2,39–41 To assist with the
resulting healthcare management challenges, as we
presented in our previous work related with health-
care management issues, there have been serious
developments worldwide to develop and implement
programmes and guidelines to promote quality
improvements in healthcare, such as accreditation
and certification programmes.24,42–48
Related to the barriers here defined as ‘assess-
ment/evaluation methods’ and ‘leadership’ in
healthcare organizations, key international organiz-
ations (i.e. WHO, Organisation for Economic
Co-operation and Development, Institute for
Healthcare Improvement – IHI) have developed rec-
ommendations and guidelines to improve the
quality of the care delivered.49–51 Also, the lack of
effective ‘surveillance methods’ is identified in the
literature as a key barrier and it has been reported
as a problem for HAIs prevention and control due
to simple inexistence of any such effort or due to
the poor quality of existing surveillance methods
and programmes.52,53 Surveillance programmes are
fundamental for HAIs prevention and control
systems. Inexistence or inappropriate surveillance
systems imply that there will be no information
and scientific evidence on the evolution of HAIs
and no clear focus on measures to implement. To
tackle this problem some international guidelines
and programmes were developed to promote the
implementation and the quality of organizational
surveillance programmes, including those presented
in 2009 by the WHO in the ‘Core Components for
Infection Prevention and Control Programmes’ and
by the European Union in related Council
Recommendations.16,24,43 On the basis of these
recommendations many European countries are
currently undertaking surveillance programmes.
Concerning the dimension defined as ‘results’
three barriers were identified: data quality, data
treatment, and reporting/communication. These
barriers are clearly related with the lack of effective
‘surveillance methods’ and related with the absence
of reliable epidemiological data. In the USA, a report
for 11 states argues that the quality of existing data is
often questionable given the difficulties presented
by the reporting methodology. Owing to this key
healthcare management factor, during the last
years a number of networks were established to
support and promote the quality of healthcare man-
agement data and the quality of data reporting/
communication methods.37 One of the long-term
networks dedicated to this purpose is the HELICS
project created in 1997 (actually part of the
Improving Patient Safety in Europe (IPSE) pro-
gramme), the EUInfoPas created by the European
Union in 2006 (to encourage and support member
states in establishing effective patient safety report-
ing systems) and recently the HAI-Net Project devel-
oped at European union level in 2011.24,37
Conclusions
A set of healthcare management barriers to the
development of effective HAIs prevention and
control programmes has been identified in this
study. This is a contribution to the international
debate on healthcare management approaches to
tackle HAIs. This study is a structured update on
the key barriers and related recommendations and
guidelines developed to overcome difficulties in
implementing effective HAIs’ prevention and
control systems. From the recommendations and
guidelines identified, it is clear that a bundle of
actions and interventions have been developed
both at organizational level and health system
level since, at least, 2001. These recommendations
and barriers were identified in our previous research
that also looked into additional healthcare manage-
ment issues. Yet, the problem persists. The literature
review performed allows to state that it does not
seem to be a lack of pertinent recommendations
and guidelines and even related solutions to tackle
high levels of HAIs. The key problem seems to be
on how these are adopted, adapted, developed,
implemented, maintained, and evaluated in health-
care organizations. In essence, it is now a problem of
effective healthcare management.
The international healthcare management com-
munity should be open to critically appraise and
review the approaches adopted to tackle this key
contemporary challenge of healthcare organizations.
Further research is needed to explore and clarify
why and how failures on effective and sustainable
management systems to promote HAIs prevention
and control systems are occurring. If it is not due
to the lack of pertinent programmes, systems and
related organizational options and solutions, it
must be due to how these are being implemented.
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